Plumb Pharmaceuticals Inc.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Plumb Pharmaceuticals Inc. - overview
Established
2016
Location
Madison, WI, US
Primary Industry
Pharmaceuticals
About
Based in Wisconsin, US, and founded in 2016 by Lisa Krugner-Higby, and Timothy D. Heath, Plumb Pharmaceuticals Inc. operates as a pharmaceutical company that develops a drug delivery platform that offers antibiotics, antipsychotics, anticancer chemotherapy, etc. In January 2022, Plumb Pharmaceuticals Inc.
raised pre-seed funding from The Winnow Fund. Plumb Pharmaceuticals Inc. offers advanced quantload systems that are being developed for the production of formulations of weak-base, small-molecule drugs. The company's lipid nano-particle technology provides ADHD stimulants, anti-HIV drugs, antibiotics, antipsychotics, cancer chemotherapy agents, antihistamines, and analgesics, allowing the healthcare industry to improve human health.
Furthermore, the firm is committed to resolving medication compliance issues through the use of extended-release formulations of FDA-approved drugs.
Current Investors
The Winnow Fund
Primary Industry
Pharmaceuticals
Sub Industries
Biotechnology, Pharmaceuticals
Website
www.plumbpharma.com
Verticals
Manufacturing
Company Stage
Early Stage
Total Amount Raised
Subscriber access only
Plumb Pharmaceuticals Inc. - employee data
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.